NCT00768521 A Study to Test the Effects of Tolterodine Tartrate in Patients With Overactive Bladder (0000-107) Status COMPLETED Phase PHASE1
NCT00768170 MK0633 Single Dose Study in Japanese Asthmatic Children Aged 12 to Less Than 16 Years (0633-028) Status COMPLETED Phase PHASE1
NCT00767897 The Impact of the Human Papilloma Virus in Pediatric Chronic Kidney Disease, Dialysis, and Transplant Patients Status COMPLETED Phase N/A
NCT00767793 A Placebo-Controlled Study of INS117548 Ophthalmic Solution in Subjects With Glaucoma (P08650) Status COMPLETED Phase PHASE1
NCT00767364 Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome Status COMPLETED Phase PHASE1
NCT00767000 Dose Range Finding Study of MK-0941 in Patients With Type 2 Diabetes Mellitus on Insulin (MK-0941-007 AM3 EXT1 AM1)(TERMINATED) Status TERMINATED Phase PHASE2
NCT00764946 A Study of Raltegravir in a Diverse Cohort of HIV-Infected Patients (0518-055) Status COMPLETED Phase PHASE3
NCT00764660 Trial Investigating the Efficacy and Safety of SCH 900435 (Org 25935) in Relapse Prevention in Participants With Alcohol Dependence (P05718) Status TERMINATED Phase PHASE2
NCT00763685 Study to Evaluate the Efficacy of Pre-operative Administration of Etoricoxib 120 mg, Etoricoxib 120 mg and Paracetamol 1 g Combination or Placebo in the Treatment of Postoperative Pain in Patients Undergoing Gynaecologic Laparoscopic Surgery Status TERMINATED Phase PHASE4
NCT00762983 Observation of Use of Claritin (Loratadine) Tablet, RediTabs, and Dry Syrup in Children (Study P05834)(COMPLETED) Status COMPLETED Phase N/A
NCT00762892 Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected Patients Status COMPLETED Phase PHASE4
NCT00762255 A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma Status COMPLETED Phase PHASE1
NCT00761735 5 Year Long-term Follow up in Pediatric Participants Who Received PegIntron Plus Rebetol in P02538 Part I (P02538 Pt 2) Status COMPLETED Phase PHASE3
NCT00759785 A Study of Dalotuzumab (MK-0646) in Breast Cancer Patients (MK-0646-013) Status COMPLETED Phase PHASE1
NCT00759109 Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085) Status COMPLETED Phase PHASE3
NCT00758836 A Study to Test the Safety and Effectiveness of MK-0974 (Telcagepant) Co-administered With Ibuprofen or Acetaminophen in Patients With Migraines With or Without Aura (MK-0974-046) Status COMPLETED Phase PHASE2
NCT00758680 A Multiple-Dose Study of MK-1006 (MK-1006-004)(TERMINATED) Status TERMINATED Phase PHASE1
NCT00758485 Comparing 4.0 mg.Kg-1 Sugammadex With Placebo in the Reversal of Profound Neuromuscular Blockade (P05767) Status COMPLETED Phase PHASE3
NCT00758069 Clinical Study on Sitagliptin for Assessment of Glucose-lowering Effects (0431-045) Status COMPLETED Phase PHASE2
NCT00757939 A Study to Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED) Status COMPLETED Phase PHASE1